Figure 2.
Discharge status among 6442 adult patients with AML who received cytarabine-anthracycline-based IC by age.

Discharge status among 6442 adult patients with AML who received cytarabine-anthracycline-based IC by age.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal